by LMC Manna Research | Feb 27, 2019 | Uncategorized
LMC Manna Research’s Chief Medical officer Dr. Ronnie Aronson shares our latest publication showcasing our collaborative work with the medications lixisenatide and LixiLan (lixisenatide & lantus combination) over the past decade. This publication is a...
by LMC Manna Research | Feb 1, 2019 | Uncategorized
With one month of 2019 already completed, we are excited to share a 2nd FIT published paper from LMC Manna Research’s very own Scientist Team led by Chief Medical Officer Dr. Ronnie Aronson and Senior Scientist Michael Riddell. This 2nd paper highlights that High...
by LMC Manna Research | Sep 25, 2018 | Uncategorized
LMC Healthcare & LMC Manna Researches own Drs. Ronnie Aronson, Harpreet Bajaj, and Ruth Brown’s manuscript titled “SGLT2 inhibitors and incretin agents: associations with alanine aminotransferase activity in type 2 diabetes” has been accepted to...
by LMC Manna Research | Sep 25, 2018 | Uncategorized
Guest Columnists: Nazneen Qureshi, Manager, Patient Engagement, LMC Manna Research & Mary K.D. D’Rozario, President, Clinical Research Performance, Inc. Millennials aren’t kids any more — as the oldest members of the generation enter their 40s, they are a...
by LMC Manna Research | May 28, 2018 | Uncategorized
Acquisition strengthens growing network’s resources to service pharmaceutical and research partners globally Press Release: Clinical Leader LMC Manna Research – the largest network of fully-owned and integrated clinical research sites in Canada providing Phase I-IV...
by LMC Manna Research | May 28, 2018 | Uncategorized
Sanofi: Accelerating Future Breakthroughs Through Clinical Trials: Part 2 of 3 For biopharmaceutical companies looking to streamline the clinical trial process, “big data” can be a big challenge. From complex genomics to the constant stream of patient data from mobile...
